VIP
156 RCTsWell researched
| Broad, well-documented physiological roles | supported |
| Intranasal VIP treats chronic inflammatory illness | weak evidence |
Goal matrix
Every compound we track for this goal.
| Broad, well-documented physiological roles | supported |
| Intranasal VIP treats chronic inflammatory illness | weak evidence |
| Approved in several countries for chronic hepatitis B | supported |
| Modulates T-cell function | supported |
| Boosts immunity in healthy people | weak evidence |
| Kills microbes in laboratory models | preclinical only |
| A core component of human innate immunity | supported |
| Treats chronic infections when injected | weak evidence |
| Reduces inflammation in gut and skin models | animal data only |
| Treats inflammatory bowel disease in humans | weak evidence |
All content on Peptuity is provided for research and educational purposes only. Peptuity does not sell, distribute, or facilitate the purchase of any compound, does not provide medical advice, and makes no claims regarding safety or efficacy. Most compounds discussed are not approved for human use by the SFDA or FDA. Always consult a qualified physician.